Reported 1 day ago
UnitedHealth Group's stock fell nearly 4% in premarket trading following news of a Department of Justice investigation into its Medicare program participation, contributing to a 44.3% drop this year. Concerns over regulatory risks and rising medical costs, along with a leadership change, have created uncertainty for investors. Despite independent audits supporting the company's practices, analysts suggest caution, as regulatory pressures continue to weigh on the stock's outlook.
Source: YAHOO